Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatment.

International journal of molecular medicine

Volumn 10, Issue 3, 2002, Pages 251-256

  Rha, Sun Young ^a   Jeung, Hei Cheul ^a   Roh, Jae Kyung ^a   Kim, Jin Ju ^a   Noh, Sung Hoon ^a   Min, Jin Sik ^a   Kim, Byung Soo ^a   Chung, Hyun Cheol ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; GABEXATE; MATRIX METALLOPROTEINASE; SERINE PROTEINASE INHIBITOR;

ADENOCARCINOMA; ADULT; AGE; AGED; ARTICLE; CELL DIFFERENTIATION; DRUG ANTAGONISM; FEMALE; HUMAN; IC 50; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PHENOTYPE; PROGNOSIS; STOMACH TUMOR; TIME; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; ENZYME INHIBITORS; FEMALE; GABEXATE; HUMANS; INHIBITORY CONCENTRATION 50; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; PROGNOSIS; SERINE PROTEINASE INHIBITORS; STOMACH NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 0036725924     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.10.3.251     Document Type: Article

References (0)